Publications
- Bone Mineral Density and Body Composition in Men With Multiple Sclerosis Chronically Treated With Low-Dose Glucocorticoids2012 | First Faculty of Medicine, Faculty of Physical Education and Sport, Faculty of Pharmacy in Hradec Králové
- Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial2012 | First Faculty of Medicine
- Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial2012 | First Faculty of Medicine
- Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis2012 | First Faculty of Medicine
- Escalating therapy in multiple sclerosis2012 | First Faculty of Medicine
- Detection of multiple sclerosis in the general practitioner2012 | First Faculty of Medicine
- The clinical standard for the diagnosis and treatment of multiple sclerosis and neuromyelitis optica2012 | First Faculty of Medicine
- Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome2012 | First Faculty of Medicine
- Cortical Pathology in Multiple Sclerosis - Morphology, Immunopathology and Clinical Context2012 | First Faculty of Medicine
- Limited walking ability significantly contributes to a loss of bone mineral density in the proximal femur in premenopausal and postmenopausal women with multiple sclerosis2012 | First Faculty of Medicine
Loading network view...